Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Endpoint Clinical
AddedFeb 15, 2024
UpdatedJun 18, 2026
Endpoint Clinical

Endpoint Clinical

Seed

Study software provider, Endpoint, designs and tests interactive data access platforms via phones.

HQ
San Francisco, CA, US
Founded
2009
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to streamline clinical trials, Endpoint Clinical specializes in designing and testing interactive response technology (IRT) platforms. Their core vision is to simplify and enhance drug supply management and trial administration through innovative software solutions. Endpoint Clinical offers products that facilitate patient randomization and clinical supply management, ensuring efficient and error-free trial processes. Their market focus includes pharmaceutical companies and clinical research organizations seeking to optimize their study operations.

Notable figures affiliated with Endpoint Clinical include industry experts in clinical trial management and software engineering, although specific names are not provided. The company has achieved significant milestones, such as developing custom IRT systems within a month and saving clients over $1 million by preventing costly errors. Endpoint Clinical's impact on the industry is marked by its ability to refine complex randomization and trial supply methods, thereby improving the overall efficiency and reliability of clinical trials.

Endpoint Clinical - Similar Companies

Clinical Research IO logo

Clinical Research IO

Clinical.Ly logo

Clinical.Ly

clinical.ly

4G Clinical logo

4G Clinical

Curebase logo

Curebase

curebase.com

ClinOne logo

ClinOne

clinone.com

iClinical logo

iClinical

Korio logo

Korio

korioclinical.com

Citruslabs logo

Citruslabs

citruslabs.com

On-Time Trials logo

On-Time Trials

ontimetrials.com

ClinCapture logo

ClinCapture

clincapture.com

Medable logo

Medable

medable.com

Atreo logo

Atreo

atreo.io

Strategikon Pharma logo

Strategikon Pharma

Algorics logo

Algorics

Suvoda logo

Suvoda

suvoda.com

Endpoint Clinical - Quick Facts

Who are Endpoint Clinical's competitors?

Companies similar to Endpoint Clinical include Clinical Research IO, Clinical.Ly, 4G Clinical and Curebase.

When was Endpoint Clinical founded?

Endpoint Clinical was founded in 2009.

Where is Endpoint Clinical's headquarters located?

Endpoint Clinical's headquarters is located in San Francisco, CA, US.

When was Endpoint Clinical's last funding round?

Endpoint Clinical's most recent funding round was for $1.7M (USD) in March 2010.

How much has Endpoint Clinical raised to-date?

As of Mar 1, 2010, Endpoint Clinical has raised a total of $1.7M (USD).

How many employees does Endpoint Clinical have?

Endpoint Clinical has 606 employees as of Feb 5, 2024.

Endpoint Clinical - Classification

Ownership
  • Private
Technology
  • Analytics
  • IRT
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Clinical Trial Software
Tags
  • Healthtech
  • SaaS
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
ISIC
  • 8690Other human health activities
Show 8 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621500Medical and Diagnostic Laboratories
  • 621510Medical and Diagnostic Laboratories
  • 621511Medical Laboratories
  • 620000Health Care and Social Assistance
SIC
  • 8070Medical And Dental Laboratories
  • 8071Medical Laboratories
  • 8000Health Services